LiveHealth+: 🇪🇺 Europe: EU Grants Approval to First Antiviral Approved for Ac…

Posted by LiveHealth+ on LiveHealth+

🇪🇺 Europe: EU Grants Approval to First Antiviral Approved for Acute Hepatitis CIn a sweeping victory for viral disease elimination goals, the European Commission officially approved AbbVie’s oral pangenotypic antiviral therapy, Maviret, today. * The Milestone: Maviret is now the first and only treatment approved in the European Union to treat both acute and chronic Hepatitis C virus (HCV) infections in patients as young as three. * The Strategy: Previously, clinical systems frequently faced lengthy bureaucratic delays waiting for acute cases to transition to chronic status. This direct regulatory shift allows doctors to prescribe curative therapy immediately upon initial diagnosis, blunting the progression of liver cirrhosis and stopping onward community transmission. Source: European Commission Regulatory Registry